Brief: Vascular Biogenics files Prospectus Relates To Resale By Selling Shareholders Of Up To 11.5 Million Ordinary Shares That Are Issuable Upon Exercise Of Warrants
01/06/2020 18:09
June 1 (Reuters) - Vascular Biogenics Ltd VBLT.O :
* VASCULAR BIOGENICS-PROSPECTUS RELATES TO RESALE BY SELLING
SHAREHOLDERS OF UP TO 11.5 MILLION ORDINARY SHARES THAT ARE
ISSUABLE UPON EXERCISE OF WARRANTS
* VASCULAR BIOGENICS SAYS SELLING SHAREHOLDERS MAY OFFER THE
SHARES FROM TIME TO TIME THROUGH PUBLIC OR PRIVATE TRANSACTIONS
- SEC FILING
Source text - https://bit.ly/2Bi2BS9
Further company coverage: VBLT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Notable Labs
See all newsUS STOCKS-Wall St ends sharply lower following Trump's anti-Powell tirade
US STOCKS-Wall St ends sharply lower amid Trump's tirade against Fed's Powell
US STOCKS-Wall St tumbles as Trump ramps up tirade against Fed's Powell
Brief: Notable Labs Says Co, Units Filed Voluntary Petition Under Provisions Of Chapter 7 Of Title 11 Of US Bankruptcy Code
Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives